Alnylam Pharmaceuticals, Inc. (ALNY)
328.70
+20.65
(+6.70%)
USD |
NASDAQ |
Mar 25, 16:00
326.03
-2.67
(-0.81%)
After-Hours: 20:00
Alnylam Pharmaceuticals Free Cash Flow : 465.38M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 9.076B |
| Eli Lilly & Co. | 5.964B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Bristol Myers Squibb Co. | 12.84B |
| Insmed, Inc. | -997.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 163.56M |
| Cash from Investing (Quarterly) | -37.17M |
| Cash from Financing (Quarterly) | 45.32M |
| Free Cash Flow Per Share (Quarterly) | 1.029 |
| Free Cash Flow to Equity (Quarterly) | -55.23M |
| Free Cash Flow to Firm (Quarterly) | 289.89M |
| Free Cash Flow Yield | 1.06% |